Previous 10 | Next 10 |
Inogen (NASDAQ:INGN): Q2 GAAP EPS of $0.22 beats by $0.33. Revenue of $101.56M (+41.7% Y/Y) beats by $12.81M. Press Release For further details see: Inogen EPS beats by $0.33, beats on revenue
– Q2 2021 Record Total Revenue of $101.6 million, up 41.7% from the same period in 2020 – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial r...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021. The Company will host a cor...
Inogen (INGN) announces the appointment of Stanislav Glezer as the company's Executive Vice President and Chief Medical Officer, effective June 21, 2021.Glezer has over 25 years of experience in clinical research and medical affair roles.Most recently, Glezer was with Becton, D...
- Dr. Stanislav Glezer to join as Executive Vice President and Chief Medical Officer Effective June 21, 2021 - Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Boa...
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora has been appointed to its Board of Directors, effective May 24, 2021. In addition, Ms. Mora was appointed as a m...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 41 st Annual William Blair Virtual Growth Stock Conference. ...
The following slide deck was published by Inogen, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Inogen, Inc. 2021 Q1 - Results - Earnings Call Presentation
Inogen, Inc. (INGN) Q1 2021 Earnings Conference Call May 04, 2021, 04:30 PM ET Company Participants Ali Bauerlein - Chief Financial Officer and Co-Founder Nabil Shabshab - President and Chief Executive Officer Conference Call Participants Matthew Mishan - KeyBanc Margaret Kaczor - William Bla...
Image source: The Motley Fool. Inogen Inc (NASDAQ: INGN) Q1 2021 Earnings Call May 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inogen Inc (INGN) Q1 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...